DEVELOPMENT AND COMMERCIALIZATION LICENSE AGREEMENTDevelopment and Commercialization License Agreement • February 27th, 2015 • Opko Health, Inc. • Pharmaceutical preparations • New York
This Development and Commercialization License Agreement (the “Agreement”) is entered into as of December 13, 2014 (the “Execution Date”), by and between Pfizer Inc., a Delaware corporation with offices located at 235 East 42nd Street, New York, New York 10017 (“Pfizer”) and OPKO Ireland Ltd., an entity organized and existing under the laws of Ireland (“OPKO”). Pfizer and OPKO are referred to herein individually as a “Party” and collectively as the “Parties.”
